Maxx Orthopedics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.2Mgeneral payments (2019-2025)
$485Kresearch payments (2019-2025)
222clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $649K
2020 $403K
2021 $186K
2022 $239K
2023 $576K
2024 $97K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Orthopaedic Surgery $1.7M
Adult Reconstructive Orthopaedic Surgery $337K
Surgery $53K
Sports Medicine (Orthopaedic Surgery) $23K
Orthopaedic Trauma $2,728
Thoracic Surgery (Cardiothoracic Vascular Surgery) $390

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Asit Shah Englewood, NJ Orthopaedic Surgery $698,028.66
Sridhar Durbhakula Bethesda, MD Adult Reconstructive Orthopaedic Surgery $285,136.31
Mark Munro Orlando, FL Orthopaedic Surgery $123,561.95
Carl Becker Lancaster, PA Orthopaedic Surgery $109,967.96
Scott Miller Melbourne, FL Orthopaedic Surgery $101,552.98
Thomas Cook Dayton, OH Orthopaedic Surgery $86,625.44
Mark Powers Port St Lucie, FL Orthopaedic Surgery $80,540.21
Jonathan Saluta Los Angeles, CA Surgery $53,143.73
John Moor Sarasota, FL Orthopaedic Surgery $49,127.29
David Lionberger Houston, TX Orthopaedic Surgery $45,418.81

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.